long term semaglutide use Semaglutide: Double-edged Sword with Risks and Benefits FDA Approves Oral Semaglutide for

Telehealth consults are available for Connecticut residents

FIRMS NOT OFFERING HEALTH BENEFITS Firms that do not offer health benefits were asked several questions, including whether they have offered insurance or shopped for insurance in the recent past, what their most important reasons for not offering coverage are, and their opinion on whether their employees would prefer an increase in wages or health insurance if additional funds were available to increase their compensation

Our GLP-1 guide explains the mechanism and trial data in more detail

First-time prescribing of ADMs decreased slightly in March 2025 relative to December (-6.56%), while first-time prescribing of AOMs increased from December 2024 to January 2025, before remaining relatively stable until March 2025 (+18.63%)

officinale , comprehensive efficacy, pharmacokinetic, and safety studies should be conducted, followed by clinical trials